Cargando…
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
The purpose of this study was to compare chemotherapy-naive patients with stage IV nonsmall cell lung cancer patients treated with chemotherapy or chemoimmunotherapy. We tested doxetacel plus cisplatinum as chemotherapy protocol. An immunomodulatory adjuvant system was added as chemoimmunotherapy to...
Autores principales: | Lasalvia-Prisco, Eduardo, Garcia-Giralt, Emilio, Vázquez, Jesús, Aghazarian, Marta, Lasalvia-Galante, Eduardo, Larrañaga, Joshemaria, Spera, Gonzalo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721394/ https://www.ncbi.nlm.nih.gov/pubmed/19707385 |
Ejemplares similares
-
Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2012) -
Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2007) -
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2016) -
‘Mate’ Intake, Hormone-Based Risk Factors and Breast Cancer: a Case-Control Study
por: Ronco, Alvaro L, et al.
Publicado: (2017) -
Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies—A Case Report and Review of the Literature
por: Jhaveri, Vimal V, et al.
Publicado: (2019)